STTCOMP PTX FA LONG Been a long time plodder this one but then with med stocks this can be par for the course. But recent FastTrack destination by U.S FDA has shoved their highly promising drug PTX-100 Firmly in the spotlight. Will gain faster access to trial recipients into phase 2 trails and if they keep meeting end points on FDA markers will be on the Fastlane to full approval. Thats still s long way in medical terms but thing are definitely on the rise for this little gem. 38 Million cap at 5 cents a share = bargain.
